Inventor · disambiguated record
Markus Haeberlein
Also filed as: HAEBERLEIN MARKUS
13 granted patents·12 pending applications·43 citations·filing 2002–2023
88Inventor score
Files withASTRAZENECA AB6PROTEOSTASIS THERAPEUTICS INC4ALKERMES INC3ALKERMES PHARMA IRELAND LTD3KINETA INC2
Top patents by PatentIndex Score
25 records- 0191US9850262B2Proteasome activity enhancing compoundsPROTEOSTASIS THERAPEUTICS INC·Filed 2016·Granted Dec 26, 2017·6 cites·25 claims
- 0290US11242361B2Proteasome activity enhancing compoundsPROTEOSTASIS THERAPEUTICS INC·Filed 2020·Granted Feb 8, 2022·2 cites·34 claims
- 0384US11746098B2Proteasome activity enhancing compoundsPROTEOSTASIS THERAPEUTICS INC·Filed 2020·Granted Sep 5, 2023·1 cites·25 claims
- 0482US6812225B2Therapeutic heterocyclic compoundsASTRAZENECA AB·Filed 2002·Granted Nov 2, 2004·16 cites·9 claims
- 0581US10604489B2Compounds for the treatment of painALKERMES INC·Filed 2019·Granted Mar 31, 2020·1 cites·16 claims
- 0676US11958873B2Proteasome activity enhancing compoundsKINETA INC·Filed 2021·Granted Apr 16, 2024·0 cites·35 claims
- 0774US7045514B2Therapeutic heterocyclic compoundsASTRAZENECA AB·Filed 2004·Granted May 16, 2006·6 cites·12 claims
- 0874US7026314B2Therapeutic chromone compoundsASTRAZENECA AB·Filed 2002·Granted Apr 11, 2006·10 cites·52 claims
- 0973US7285662B2Therapeutic heterocyclic compoundsASTRAZENECA AB·Filed 2005·Granted Oct 23, 2007·1 cites·6 claims
- 1071US2024116894A1Proteasome activity enhancing compoundsKINETA INC·Filed 2023·Application pending·0 cites
- 1169US2022033394A1Compounds for the treatment of painALKERMES INC·Filed 2021·Application pending·0 cites
- 1267US11180455B2Compounds for the treatment of painALKERMES INC·Filed 2020·Granted Nov 23, 2021·0 cites·16 claims
- 1364US2018282352A1Proteasome activity enhancing compoundsPROTEOSTASIS THERAPEUTICS INC·Filed 2017·Application pending·0 cites
- 1461US10975099B2Thiophene compounds for long-acting injectable compositions and related methodsALKERMES PHARMA IRELAND LTD·Filed 2019·Granted Apr 13, 2021·0 cites·17 claims
- 1560US10807995B2Thienothiophene compounds for long-acting injectable compositions and related methodsALKERMES PHARMA IRELAND LTD·Filed 2019·Granted Oct 20, 2020·0 cites·13 claims
- 1660US2008076759A1Therapeutic Heterocyclic Compounds 507ASTRAZENECA AB·Filed 2007·Application pending·0 cites
- 1750US2006178372A1Therapeutic quinoline compoundsASTRAZENECA AB·Filed 2006·Application pending·0 cites
- 1847US10799496B2Naphthylenyl compounds for long-acting injectable compositions and related methodsALKERMES PHARMA IRELAND LTD·Filed 2019·Granted Oct 13, 2020·0 cites·18 claims
- 1945US2005096312A1Therapeutic quinolone compounds with 5-ht-antagonistic propertiesFiled 2002·Application pending·0 cites
- 2042US2006019947A1Therapeutic chromone compoundsCHAPDELAINE MARC·Filed 2005·Application pending·0 cites
- 2139US2005085457A1Therapeutic quinolone compounds with 5-ht-antagonistic propertiesFiled 2002·Application pending·0 cites
- 2239US2007010526A1Therapeutic isoquinoline compoundsHAEBERLEIN MARKUS·Filed 2002·Application pending·0 cites
- 2336US2009192190A1Benzoic Acid Derivatives that are Modulators or Agonists of GlyRGYBACK HELENA·Filed 2006·Application pending·0 cites
- 2436US2004082591A1Therapeutic heterocyclic compoundsFiled 2002·Application pending·0 cites
- 2536US2004110745A1Therapeutic chroman compoundsFiled 2002·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Markus Haeberlein files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →